Hepatitis C virus infection in phenotypically distinct Huh7 cell lines.

by Bruno Sainz, Naina Barretto, Susan L Uprichard
Published 2009-08-01

Accounting for Space—Quantification of Cell-To-Cell Transmission Kinetics Using Virus Dynamics Models

by Peter Kumberger, Karina Durso-Cain, Susan L. Uprichard, Harel Dahari, Frederik Graw
Published 2018-04-01

Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies

by Miguel Malespin, Tamara Benyashvili, Susan L. Uprichard, Alan S. Perelson, Harel Dahari, Scott J. Cotler
Published 2017-01-01

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.

by Laetitia Canini, Michio Imamura, Yoshiiku Kawakami, Susan L Uprichard, Scott J Cotler, Harel Dahari, Kazuaki Chayama
Published 2017-01-01

Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha.

by Lie Li, Claudia E Oropeza, Bruno Sainz, Susan L Uprichard, Frank J Gonzalez, Alan McLachlan
Published 2009-01-01

HCV Spread Kinetics Reveal Varying Contributions of Transmission Modes to Infection Dynamics

by Karina Durso-Cain, Peter Kumberger, Yannik Schälte, Theresa Fink, Harel Dahari, Jan Hasenauer, Susan L. Uprichard, Frederik Graw
Published 2021-07-01

Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients

by Xufang Deng, Monika Evdokimova, Amornrat O’Brien, Cynthia L. Rowe, Nina M. Clark, Amanda Harrington, Gail E. Reid, Susan L. Uprichard, Susan C. Baker
Published 2021-09-01

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection

by Masataka Tsuge, Takuro Uchida, Kevin Walsh, Yuji Ishida, Chise Tateno, Upendra Kumar, Jeffrey S. Glenn, Christopher Koh, Theo Heller, Susan L. Uprichard, Harel Dahari, Kazuaki Chayama
Published 2019-03-01

HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir

by Harel Dahari, Laetitia Canini, Frederik Graw, Susan L. Uprichard, EvaldoS A. Araujo, Guillaume Penaranda, Emilie Coquet, Aurélie Riso, Christophe Renou, Marc Bourlière, Scott J. Cotler, Philippe Halfon
Published 2016-05-01

High-throughput screening (HTS) and hit validation to identify small molecule inhibitors with activity against NS3/4A proteases from multiple hepatitis C virus genotypes.

by Hyun Lee, Tian Zhu, Kavankumar Patel, Yan-Yan Zhang, Lena Truong, Kirk E Hevener, Joseph L Gatuz, Gitanjali Subramanya, Hyun-Young Jeong, Susan L Uprichard, Michael E Johnson
Published 2013-01-01